Position in SVRA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$14,636,153
+$1,703,221 QoQ
Shares Held
2,375,999
+0.3% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#25
of 181 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EMERALD MUTUAL FUND ADVISERS TRUST holds $391,799,835 across 21 Biotechnology names. SVRA ranks #12 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
1,032,024 | $58,629,283 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
464,902 | $40,423,228 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,031,378 | $39,914,328 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
401,271 | $35,624,839 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
289,372 | $33,876,780 | |
| 6 | MANE |
Veradermics, Inc
|
209,924 | $25,808,056 | |
| 7 | CYTK |
Cytokinetics Inc
|
279,769 | $23,833,521 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
1,210,965 | $22,584,497 |
All Filings in SVRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,636,153 | 2,375,999 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $12,932,932 | 2,368,669 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $14,450,641 | 2,396,458 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $7,680,348 | 2,151,358 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $4,985,001 | 2,186,404 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $5,580,043 | 2,014,456 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $4,223,976 | 1,375,888 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||